Abstract:Abstract:Five new 3-(4-arylpiperazin-1-yl)-2-hydroxypropyl 4-propoxybenzoates were designed and synthesized as potential dual antihypertensive agents. The compounds were prepared as free bases and subsequently transformed to hydrochloride salts. The position of protonation of nitrogen atoms in the piperazine ring of hydrochloride salts was determined by means of 13 C-CP/MAS and 15 N-CP/MAS NMR and IR spectroscopy. Using these solid-state analytical techniques, it was found that both nitrogen atoms were protona… Show more
“…The O–H bond in the PEL-T was confirmed at 3270 cm −1 , which was not observed for PEL. This intense O–H bond signal derives from the THAM absorption peak shift at 3346 and 3287 cm −1 [ 21 , 22 ]. In addition, the disappearance of the sharp peak of the O-H stretch at 2936 cm −1 in PEL and a strong asymmetric −COO − stretching vibration at 1670 cm −1 for the carboxyl salts in PEL-T were identified, showing a shift of the PEL absorption peak at 1729 cm −1 for the C=O stretch of a carboxylic acid group [ 23 ].…”
Section: Resultsmentioning
confidence: 99%
“…In addition, the disappearance of the sharp peak of the O-H stretch at 2936 cm −1 in PEL and a strong asymmetric −COO − stretching vibration at 1670 cm −1 for the carboxyl salts in PEL-T were identified, showing a shift of the PEL absorption peak at 1729 cm −1 for the C=O stretch of a carboxylic acid group [ 23 ]. Furthermore, a number of strong bands presented in the range of 3046–2000 cm −1 in the spectrum of PEL-T are expected to be generated from overtones of protonated amine groups and the combination of stretching vibrations, whereas the N-H stretching vibration in the THAM absorption peak was observed at 3400–3100 cm −1 [ 17 , 22 ]. Furthermore, the FT-IR spectrum of PEL-T showed additional IR bands at 1000 cm −1 , which corresponds to the C-O stretching vibrations, again confirming the presence of alcohol functional group of THAM moiety in the molecule.…”
Pelubiprofen (PEL), which is a commercialized non-steroidal anti-inflammatory drug (NSAID), is associated with the risk of gastrointestinal (GI) adverse events following long-term exposure and has poor water-soluble properties. Here, a new pelubiprofen tromethamine (PEL-T) with improved solubility, permeability, GI safety, and absorption, compared to PEL, has been developed. The nuclear magnetic resonance spectroscopy (NMR), differential scanning calorimetry (DSC), and Fourier transform infrared spectroscopy (FT-IR) results confirmed that the PEL-T was well formed. The powder of PEL-T showed the presence of additional 6H protons at δ 3.66–3.61 in the 1H NMR spectrum, and shifted the sharp endothermic peaks at 129 °C in DSC, and the spectrum of distinct absorption peaks in FT-IR. In addition, compared with PEL, PEL-T showed a significantly improved solubility in various media and an increased permeability coefficient (Kp) in Caco-2 cells. Furthermore, compared to PEL oral administration, PEL-T was found to significantly reduce the damaged area in an acute gastric damage rat model. The pharmacokinetic study of the PEL-T powder showed higher maximum plasma concentration (Cmax) and area under the plasma concentration–time curve from 0 h to the last time point (AUCt) than those of the PEL powder. Taken together, our data suggest that PEL-T is a recommendable candidate with enhanced gastrointestinal safety and better absorption compared with commercial PEL.
“…The O–H bond in the PEL-T was confirmed at 3270 cm −1 , which was not observed for PEL. This intense O–H bond signal derives from the THAM absorption peak shift at 3346 and 3287 cm −1 [ 21 , 22 ]. In addition, the disappearance of the sharp peak of the O-H stretch at 2936 cm −1 in PEL and a strong asymmetric −COO − stretching vibration at 1670 cm −1 for the carboxyl salts in PEL-T were identified, showing a shift of the PEL absorption peak at 1729 cm −1 for the C=O stretch of a carboxylic acid group [ 23 ].…”
Section: Resultsmentioning
confidence: 99%
“…In addition, the disappearance of the sharp peak of the O-H stretch at 2936 cm −1 in PEL and a strong asymmetric −COO − stretching vibration at 1670 cm −1 for the carboxyl salts in PEL-T were identified, showing a shift of the PEL absorption peak at 1729 cm −1 for the C=O stretch of a carboxylic acid group [ 23 ]. Furthermore, a number of strong bands presented in the range of 3046–2000 cm −1 in the spectrum of PEL-T are expected to be generated from overtones of protonated amine groups and the combination of stretching vibrations, whereas the N-H stretching vibration in the THAM absorption peak was observed at 3400–3100 cm −1 [ 17 , 22 ]. Furthermore, the FT-IR spectrum of PEL-T showed additional IR bands at 1000 cm −1 , which corresponds to the C-O stretching vibrations, again confirming the presence of alcohol functional group of THAM moiety in the molecule.…”
Pelubiprofen (PEL), which is a commercialized non-steroidal anti-inflammatory drug (NSAID), is associated with the risk of gastrointestinal (GI) adverse events following long-term exposure and has poor water-soluble properties. Here, a new pelubiprofen tromethamine (PEL-T) with improved solubility, permeability, GI safety, and absorption, compared to PEL, has been developed. The nuclear magnetic resonance spectroscopy (NMR), differential scanning calorimetry (DSC), and Fourier transform infrared spectroscopy (FT-IR) results confirmed that the PEL-T was well formed. The powder of PEL-T showed the presence of additional 6H protons at δ 3.66–3.61 in the 1H NMR spectrum, and shifted the sharp endothermic peaks at 129 °C in DSC, and the spectrum of distinct absorption peaks in FT-IR. In addition, compared with PEL, PEL-T showed a significantly improved solubility in various media and an increased permeability coefficient (Kp) in Caco-2 cells. Furthermore, compared to PEL oral administration, PEL-T was found to significantly reduce the damaged area in an acute gastric damage rat model. The pharmacokinetic study of the PEL-T powder showed higher maximum plasma concentration (Cmax) and area under the plasma concentration–time curve from 0 h to the last time point (AUCt) than those of the PEL powder. Taken together, our data suggest that PEL-T is a recommendable candidate with enhanced gastrointestinal safety and better absorption compared with commercial PEL.
“…Chlorides of these acids formed by thionyl chloride treatment gave desired epoxides 7a–9a and 13a after reaction with 2,3-epoxypropan-1-ol [53]. In the last step final compounds 7–9 were prepared by a reaction of the epoxides with 1-(4-phenyl)piperazine and then converted to the hydrochloride salts using ethereal HCl to enhance their solubility in water [55]. …”
Sphingosine kinase 1 (SphK1), the enzyme that produces the bioactive sphingolipid metabolite, sphin-gosine-1-phosphate, is a promising new molecular target for therapeutic intervention in cancer and inflammatory diseases. In view of its importance, the main objective of this work was to find new and more potent inhibitors for this enzyme possessing different structural scaffolds than those of the known inhibitors. Our theoretical and experimental study has allowed us to identify two new structural scaffolds (three new compounds), which could be used as starting structures for the design and then the development of new inhibitors of SphK1. Our study was carried out in different steps: virtual screening, synthesis, bioassays and molecular modelling. From our results, we propose a new dihydrobenzo[b] pyrimido[5,4-f]azepine and two alkyl{3-/4-[1-hydroxy-2-(4-arylpiperazin-1-yl)ethyl]phenyl}carbamates as initial structures for the development of new inhibitors. In addition, our molecular modelling study using QTAIM calculations, allowed us to describe in detail the molecular interactions that stabilize the different Ligand-Receptor complexes. Such analyses indicate that the cationic head of the different compounds must be refined in order to obtain an increase in the binding affinity of these ligands.
“…The hydrolysis was then performed by using a 2 M solution of sodium hydroxide and the desired acids 4 – 6 were obtained by displacing with HCl, extracting to chloroform and evaporating. The final products, hydrochloride salts 7a – c , 8a – c , 9a – c , were prepared according to the already published synthesis [24]. Briefly, the appropriate acids 1–3 were transformed into the potassium salt using potassium hydroxide in a mixture of methanol and propan-2-ol (ratio 1:3).…”
Section: Resultsmentioning
confidence: 99%
“…The obtained bases were finally converted to their dihydrochloride salts by extend of hydrochloric acid to enhance the solubility of the compounds in water. The protonation of the phenylpiperazine nitrogens was not experimentally determined for the discussed final compounds but the hypothesis is based on the measurement carried out for similar structures [24].…”
Abstract:Nine new dihydrochloride salts of 3-(4-arylpiperazin-1-yl)-2-hydroxypropyl 4-alkoxyethoxybenzoates were designed and synthesized. The physicochemical properties such as lipophilicity index (log k w ) and dissociation constant (pK a ) were experimentally determined and compared to the software calculated data. The lipophilicity index was determined by means of reversed-phase high performance liquid chromatography (RP-HPLC). The pK a values were determined by means of capillary zone electrophoresis. The "drug-likeness" properties according to the Lipinski Rule of Five and prediction of possible blood-brain barrier penetration were computed and discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.